Dose-dependent effects of postmenopausal estrogen and progestin on antithrombin III and factor XII

EM Gordon, SR Williams, B Frenchek… - The Journal of …, 1988 - translationalres.com
The frequent use of estrogen and progestin replacement for treatment in postmenopausal
women makes assessment of its effect on the coagulation system of interest Although the …

Estrogen dose and progestogen type: Their effect on hemostatic changes in oral contraceptive users

LA Norris, J Bonnar - Gynecological Endocrinology, 1996 - Taylor & Francis
Greater hemostatic changes have been observed in women taktng 50 pg ethinylestrahol
(EE) combinations compared with women taktng 30 pg EE pills'. This effect may be modified …

The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: results from the estrogen in …

E Høibraaten, I Os, I Seljeflot, TO Andersen… - Thrombosis research, 2000 - Elsevier
Data on the effect of hormone replacement therapy on hemostasis are inconsistent, and
there are few data in women with coronary artery disease. In a single-center, open …

[引用][C] Effects of low-dose ethinylestradiol oral contraceptives differing in progestogen compound on coagulation and fibrinolytic-risk variables for venous and arterial …

JA Gevers Leuven, C Kluft, MC Dersjant-Roorda… - Fibrinolysis diseases. CRC …, 1996

[PDF][PDF] Chronic use of 17β‑Ethinyl estradiol on cardiovascular hemodynamic profile:“Friend or foe”?

HL Bhalla - Journal of Pharmaceutical Negative Results, 2013 - pnrjournal.com
Introduction: The effects of ovariectomy (Ovx), menopause, and estrogen replacementon the
hemodynamic remain controversial. This study employed the technique ofimpedance …

[PDF][PDF] Effects of 17beta-estradiol and phytoestrogen alpha-zearalanol on tissue factor in plasma of ovariectomized rats and HUVECs

W Wang, G Zhu, S Zu - Chinese Journal of Physiology, 2004 - cps.org.tw
Effects of 17β-Estradiol and Phytoestrogen α-Zearalanol on Tissue Factor in Plasma of
Ovariectomized Rats and HUVECs Page 1 Corresponding author: Dr. Guang-jin Zhu …

Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study

M Sgarabotto, M Baldini, A Dei Cas, C Manotti… - Thrombosis research, 2007 - Elsevier
INTRODUCTION: Hormone replacement therapy is known to increase the risk of
thromboembolic events. We compared the effects of HRT and raloxifene on some …

The influence of hormone replacement therapy containing transdermal 17-beta estradiol and oral medroxyprogesterone acetate on coagulation and fibrinolysis

G Stachowiak, D Owczarek, I Połać, T Pertyński… - Ginekologia …, 1999 - europepmc.org
The aim of the study was to evaluate some coagulative and fibrinolytic changes in women
taking hormone replacement therapy (HRT). In 29 women aged 45-64 years with …

Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with …

UH Winkler, R Krämer, B Kwee… - Zentralblatt fur …, 1995 - europepmc.org
Estrogen replacement therapy (ERT) appears to markedly reduce the risk of cardiovascular
disease in postmenopausal women. There is evidence that estrogen effects on blood …

Cardiovascular risk markers during treatment with estradiol and trimegestone or dydrogesterone

M Hellgren, J Conard, L Norris, C Kluft - Maturitas, 2009 - Elsevier
OBJECTIVE: To study cardiovascular risk markers in women taking estradiol/trimegestone or
estradiol/dydrogesterone. DESIGN: Multicenter, randomized, prospective, double-blind …